カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の季節性情動障害治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Seasonal Affective Disorder Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19616）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19616
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の季節性情動障害治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

季節性情動障害治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の季節性情動障害治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

季節性情動障害治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・SSRI、SNRI、NDRI、TCA、MOAI

用途別セグメントは次のように区分されます。
・病院薬局、オンライン薬局、リテール薬局

世界の季節性情動障害治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、GlaxoSmithKline、Bristol-Myers Squibb、Otsuka Pharmaceutical、Mylan、Merck

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、季節性情動障害治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な季節性情動障害治療薬メーカーの企業概要、2019年～2022年までの季節性情動障害治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な季節性情動障害治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別季節性情動障害治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの季節性情動障害治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での季節性情動障害治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および季節性情動障害治療薬の産業チェーンを掲載しています。
・第13、14、15章では、季節性情動障害治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 季節性情動障害治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：SSRI、SNRI、NDRI、TCA、MOAI
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、リテール薬局
- 世界の季節性情動障害治療薬市場規模・予測
- 世界の季節性情動障害治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、GlaxoSmithKline、Bristol-Myers Squibb、Otsuka Pharmaceutical、Mylan、Merck
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：SSRI、SNRI、NDRI、TCA、MOAI
・用途別分析2017年-2028年：病院薬局、オンライン薬局、リテール薬局
・季節性情動障害治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・季節性情動障害治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・季節性情動障害治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・季節性情動障害治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・季節性情動障害治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Seasonal Affective Disorder Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Seasonal Affective Disorder Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Seasonal Affective Disorder Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While SSRIs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Seasonal Affective Disorder Drugs include Pfizer, GlaxoSmithKline, Bristol-Myers Squibb, Otsuka Pharmaceutical, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Seasonal Affective Disorder Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
SSRIs
SNRIs
NDRIs
TCAs
MOAIs
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Seasonal Affective Disorder Drugs market are listed below:
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb
Otsuka Pharmaceutical
Mylan
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Seasonal Affective Disorder Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Seasonal Affective Disorder Drugs, with price, sales, revenue and global market share of Seasonal Affective Disorder Drugs from 2019 to 2022.
Chapter 3, the Seasonal Affective Disorder Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Seasonal Affective Disorder Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Seasonal Affective Disorder Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Seasonal Affective Disorder Drugs.
Chapter 13, 14, and 15, to describe Seasonal Affective Disorder Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Seasonal Affective Disorder Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Seasonal Affective Disorder Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 NDRIs
1.2.5 TCAs
1.2.6 MOAIs
1.3 Market Analysis by Application
1.3.1 Overview: Global Seasonal Affective Disorder Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Seasonal Affective Disorder Drugs Market Size & Forecast
1.4.1 Global Seasonal Affective Disorder Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Seasonal Affective Disorder Drugs Sales in Volume (2017-2028)
1.4.3 Global Seasonal Affective Disorder Drugs Price (2017-2028)
1.5 Global Seasonal Affective Disorder Drugs Production Capacity Analysis
1.5.1 Global Seasonal Affective Disorder Drugs Total Production Capacity (2017-2028)
1.5.2 Global Seasonal Affective Disorder Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Seasonal Affective Disorder Drugs Market Drivers
1.6.2 Seasonal Affective Disorder Drugs Market Restraints
1.6.3 Seasonal Affective Disorder Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Seasonal Affective Disorder Drugs Product and Services
2.1.4 Pfizer Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Seasonal Affective Disorder Drugs Product and Services
2.2.4 GlaxoSmithKline Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Product and Services
2.3.4 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Otsuka Pharmaceutical
2.4.1 Otsuka Pharmaceutical Details
2.4.2 Otsuka Pharmaceutical Major Business
2.4.3 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Product and Services
2.4.4 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Seasonal Affective Disorder Drugs Product and Services
2.5.4 Mylan Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Seasonal Affective Disorder Drugs Product and Services
2.6.4 Merck Seasonal Affective Disorder Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Seasonal Affective Disorder Drugs Breakdown Data by Manufacturer
3.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Seasonal Affective Disorder Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Seasonal Affective Disorder Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Seasonal Affective Disorder Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Seasonal Affective Disorder Drugs Manufacturer Market Share in 2021
3.5 Global Seasonal Affective Disorder Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Seasonal Affective Disorder Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Seasonal Affective Disorder Drugs Market Size by Region
4.1.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Seasonal Affective Disorder Drugs Revenue by Region (2017-2028)
4.2 North America Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.3 Europe Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.4 Asia-Pacific Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.5 South America Seasonal Affective Disorder Drugs Revenue (2017-2028)
4.6 Middle East and Africa Seasonal Affective Disorder Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Type (2017-2028)
5.2 Global Seasonal Affective Disorder Drugs Revenue by Type (2017-2028)
5.3 Global Seasonal Affective Disorder Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Seasonal Affective Disorder Drugs Sales in Volume by Application (2017-2028)
6.2 Global Seasonal Affective Disorder Drugs Revenue by Application (2017-2028)
6.3 Global Seasonal Affective Disorder Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
7.2 North America Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
7.3 North America Seasonal Affective Disorder Drugs Market Size by Country
7.3.1 North America Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
8.2 Europe Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
8.3 Europe Seasonal Affective Disorder Drugs Market Size by Country
8.3.1 Europe Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Seasonal Affective Disorder Drugs Market Size by Region
9.3.1 Asia-Pacific Seasonal Affective Disorder Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Seasonal Affective Disorder Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
10.2 South America Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
10.3 South America Seasonal Affective Disorder Drugs Market Size by Country
10.3.1 South America Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Seasonal Affective Disorder Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Seasonal Affective Disorder Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Seasonal Affective Disorder Drugs Market Size by Country
11.3.1 Middle East & Africa Seasonal Affective Disorder Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Seasonal Affective Disorder Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Seasonal Affective Disorder Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Seasonal Affective Disorder Drugs
12.3 Seasonal Affective Disorder Drugs Production Process
12.4 Seasonal Affective Disorder Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Seasonal Affective Disorder Drugs Typical Distributors
13.3 Seasonal Affective Disorder Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Seasonal Affective Disorder Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Seasonal Affective Disorder Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Seasonal Affective Disorder Drugs Product and Services
Table 6. Pfizer Seasonal Affective Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Seasonal Affective Disorder Drugs Product and Services
Table 10. GlaxoSmithKline Seasonal Affective Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Seasonal Affective Disorder Drugs Product and Services
Table 14. Bristol-Myers Squibb Seasonal Affective Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Otsuka Pharmaceutical Major Business
Table 17. Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Product and Services
Table 18. Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Seasonal Affective Disorder Drugs Product and Services
Table 22. Mylan Seasonal Affective Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Seasonal Affective Disorder Drugs Product and Services
Table 26. Merck Seasonal Affective Disorder Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Seasonal Affective Disorder Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Seasonal Affective Disorder Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Seasonal Affective Disorder Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Seasonal Affective Disorder Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Seasonal Affective Disorder Drugs Production Site of Key Manufacturer
Table 32. Seasonal Affective Disorder Drugs New Entrant and Capacity Expansion Plans
Table 33. Seasonal Affective Disorder Drugs Mergers & Acquisitions in the Past Five Years
Table 34. Global Seasonal Affective Disorder Drugs Sales by Region (2017-2022) & (K Units)
Table 35. Global Seasonal Affective Disorder Drugs Sales by Region (2023-2028) & (K Units)
Table 36. Global Seasonal Affective Disorder Drugs Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Seasonal Affective Disorder Drugs Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Seasonal Affective Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Global Seasonal Affective Disorder Drugs Sales by Type (2023-2028) & (K Units)
Table 40. Global Seasonal Affective Disorder Drugs Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Seasonal Affective Disorder Drugs Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Seasonal Affective Disorder Drugs Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Seasonal Affective Disorder Drugs Price by Type (2023-2028) & (USD/Unit)
Table 44. Global Seasonal Affective Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 45. Global Seasonal Affective Disorder Drugs Sales by Application (2023-2028) & (K Units)
Table 46. Global Seasonal Affective Disorder Drugs Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Seasonal Affective Disorder Drugs Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Seasonal Affective Disorder Drugs Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Seasonal Affective Disorder Drugs Price by Application (2023-2028) & (USD/Unit)
Table 50. North America Seasonal Affective Disorder Drugs Sales by Country (2017-2022) & (K Units)
Table 51. North America Seasonal Affective Disorder Drugs Sales by Country (2023-2028) & (K Units)
Table 52. North America Seasonal Affective Disorder Drugs Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Seasonal Affective Disorder Drugs Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Seasonal Affective Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 55. North America Seasonal Affective Disorder Drugs Sales by Type (2023-2028) & (K Units)
Table 56. North America Seasonal Affective Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 57. North America Seasonal Affective Disorder Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Europe Seasonal Affective Disorder Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Europe Seasonal Affective Disorder Drugs Sales by Country (2023-2028) & (K Units)
Table 60. Europe Seasonal Affective Disorder Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Seasonal Affective Disorder Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Seasonal Affective Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Europe Seasonal Affective Disorder Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Europe Seasonal Affective Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Europe Seasonal Affective Disorder Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Seasonal Affective Disorder Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Seasonal Affective Disorder Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Seasonal Affective Disorder Drugs Sales by Application (2023-2028) & (K Units)
Table 74. South America Seasonal Affective Disorder Drugs Sales by Country (2017-2022) & (K Units)
Table 75. South America Seasonal Affective Disorder Drugs Sales by Country (2023-2028) & (K Units)
Table 76. South America Seasonal Affective Disorder Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Seasonal Affective Disorder Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Seasonal Affective Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 79. South America Seasonal Affective Disorder Drugs Sales by Type (2023-2028) & (K Units)
Table 80. South America Seasonal Affective Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 81. South America Seasonal Affective Disorder Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Seasonal Affective Disorder Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Seasonal Affective Disorder Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Seasonal Affective Disorder Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Seasonal Affective Disorder Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Seasonal Affective Disorder Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Seasonal Affective Disorder Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Seasonal Affective Disorder Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Seasonal Affective Disorder Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Seasonal Affective Disorder Drugs Raw Material
Table 91. Key Manufacturers of Seasonal Affective Disorder Drugs Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Seasonal Affective Disorder Drugs Typical Distributors
Table 95. Seasonal Affective Disorder Drugs Typical Customers
List of Figures
Figure 1. Seasonal Affective Disorder Drugs Picture
Figure 2. Global Seasonal Affective Disorder Drugs Revenue Market Share by Type in 2021
Figure 3. SSRIs
Figure 4. SNRIs
Figure 5. NDRIs
Figure 6. TCAs
Figure 7. MOAIs
Figure 8. Global Seasonal Affective Disorder Drugs Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacies
Figure 10. Online Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Global Seasonal Affective Disorder Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Seasonal Affective Disorder Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Seasonal Affective Disorder Drugs Sales (2017-2028) & (K Units)
Figure 15. Global Seasonal Affective Disorder Drugs Price (2017-2028) & (USD/Unit)
Figure 16. Global Seasonal Affective Disorder Drugs Production Capacity (2017-2028) & (K Units)
Figure 17. Global Seasonal Affective Disorder Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Seasonal Affective Disorder Drugs Market Drivers
Figure 19. Seasonal Affective Disorder Drugs Market Restraints
Figure 20. Seasonal Affective Disorder Drugs Market Trends
Figure 21. Global Seasonal Affective Disorder Drugs Sales Market Share by Manufacturer in 2021
Figure 22. Global Seasonal Affective Disorder Drugs Revenue Market Share by Manufacturer in 2021
Figure 23. Seasonal Affective Disorder Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Seasonal Affective Disorder Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Seasonal Affective Disorder Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Seasonal Affective Disorder Drugs Sales Market Share by Region (2017-2028)
Figure 27. Global Seasonal Affective Disorder Drugs Revenue Market Share by Region (2017-2028)
Figure 28. North America Seasonal Affective Disorder Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Europe Seasonal Affective Disorder Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Seasonal Affective Disorder Drugs Revenue (2017-2028) & (USD Million)
Figure 31. South America Seasonal Affective Disorder Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Seasonal Affective Disorder Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Global Seasonal Affective Disorder Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global Seasonal Affective Disorder Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global Seasonal Affective Disorder Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Seasonal Affective Disorder Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Seasonal Affective Disorder Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Global Seasonal Affective Disorder Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Seasonal Affective Disorder Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Seasonal Affective Disorder Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Seasonal Affective Disorder Drugs Sales Market Share by Country (2017-2028)
Figure 42. North America Seasonal Affective Disorder Drugs Revenue Market Share by Country (2017-2028)
Figure 43. United States Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Seasonal Affective Disorder Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Seasonal Affective Disorder Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe Seasonal Affective Disorder Drugs Sales Market Share by Country (2017-2028)
Figure 49. Europe Seasonal Affective Disorder Drugs Revenue Market Share by Country (2017-2028)
Figure 50. Germany Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Seasonal Affective Disorder Drugs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Seasonal Affective Disorder Drugs Revenue Market Share by Region (2017-2028)
Figure 59. China Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Seasonal Affective Disorder Drugs Sales Market Share by Type (2017-2028)
Figure 66. South America Seasonal Affective Disorder Drugs Sales Market Share by Application (2017-2028)
Figure 67. South America Seasonal Affective Disorder Drugs Sales Market Share by Country (2017-2028)
Figure 68. South America Seasonal Affective Disorder Drugs Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Seasonal Affective Disorder Drugs Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Seasonal Affective Disorder Drugs Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Seasonal Affective Disorder Drugs Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Seasonal Affective Disorder Drugs Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Seasonal Affective Disorder Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Seasonal Affective Disorder Drugs in 2021
Figure 80. Manufacturing Process Analysis of Seasonal Affective Disorder Drugs
Figure 81. Seasonal Affective Disorder Drugs Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の季節性情動障害装置市場2022年：市場規模予測（～2028年）
  • 世界の嚥下障害製品市場2022年：市場規模予測（～2028年）
  • 世界の季節性アレルギー性鼻炎治療薬市場2022年：市場規模予測（～2028年）
  • 世界のシーズンピッチングマウンド市場2022年：市場規模予測（～2028年）
  • 出血性疾患治療薬の世界市場2023年：経口式、静脈注射式、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19616 )"世界の季節性情動障害治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Seasonal Affective Disorder Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。